Chris Stevo | SVP and Chief Investment Relations Officer |
Albert Bourla | Chairman and CEO |
Frank D'Amelio | CFO |
Mikael Dolsten | President, Worldwide Research, Development & Medical |
Angela Hwang | Group President, Pfizer Biopharmaceuticals Group |
Kerry Holford | Berenberg |
Matthew Harrison | Morgan Stanley |
Daniel Busby | RBC Capital |
Chris Schott | JPMorgan |
Ronny Gal | Bernstein |
Geoff Meacham | Bank of America |
Andrew Baum | Citi |
Carter Gould | Barclays |
Geoffrey Porges | SVB Leerink |
Louise Chen | Cantor |
Terence Flynn | Goldman Sachs |
Good day, everyone, and welcome to Pfizer's Second Quarter 2021 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investment Relations Officer. Please go ahead, sir.